| Summary of shares subject to outstanding awards |
The following details the shares subject to awards that are outstanding under the Plans as of June 30, 2026: | | | | | | | | | Restricted Stock | | RSUs | | Totals | 2025 Incentive Plan (a) | | 154,455 | | 91,075 | | 245,530 | 2022 Incentive Plan (b) | | 445,970 | | 87,500 | | 533,470 | 2019 Incentive Plan (b) | | 143,825 | | — | | 143,825 | Totals | | 744,250 | | 178,575 | | 922,825 |
| (a) | As of July 2026, the Company is deemed to have granted RSUs to acquire 90,750 shares of common stock. |
| (b) | No additional awards may be granted under such plans. |
|
| Summary of the activity of the Plans |
The following is a summary of the activity of the Plans: | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | | June 30, | | June 30, | | | | 2026 | | 2025 | | 2026 | | 2025 | | Restricted stock: | | | | | | | | | | | | | | Number of shares granted | | | — | | | — | | | 161,285 | | | 154,390 | | Average per share grant price | | $ | — | | $ | — | | $ | 21.17 | | $ | 25.52 | | Deferred compensation to be recognized over vesting period | | $ | — | | $ | — | | $ | 3,414,000 | | $ | 3,940,000 | | | | | | | | | | | | | | | | Number of non-vested shares: | | | | | | | | | | | | | | Non-vested beginning of the period | | | 744,250 | | | 742,170 | | | 728,795 | | | 727,140 | | Grants | | | — | | | — | | | 161,285 | | | 154,390 | | Vested during the period | | | — | | | (1,500) | | | (145,830) | | | (140,800) | | Forfeitures | | | — | | | (1,975) | | | — | | | (2,035) | | Non-vested end of the period | | | 744,250 | | | 738,695 | | | 744,250 | | | 738,695 | | | | | | | | | | | | | | | | RSUs (a): | | | | | | | | | | | | | | Number of non-vested shares: | | | | | | | | | | | | | | Non-vested beginning of the period | | | 263,075 | | | 256,740 | | | 263,075 | | | 256,740 | | Grants | | | — | | | — | | | — | | | — | | Vested during the period | | | (75,430) | | | (36,704) | | | (75,430) | | | (36,704) | | Forfeitures | | | (9,070) | | | (48,036) | | | (9,070) | | | (48,036) | | Non-vested end of the period | | | 178,575 | | | 172,000 | | | 178,575 | | | 172,000 | | | | | | | | | | | | | | | | Restricted stock and RSU grants (based on grant price): | | | | | | | | | | | | | | Weighted average per share value of non-vested shares | | $ | 24.76 | | $ | 24.35 | | $ | 24.76 | | $ | 24.35 | | Value of stock vested during the period | | $ | 1,533,000 | | $ | 1,007,000 | | $ | 4,505,000 | | $ | 4,922,000 | | Weighted average per share value of shares forfeited during the period | | $ | 20.32 | | $ | 26.22 | | $ | 20.32 | | $ | 26.22 | | | | | | | | | | | | | | | | Total charge to operations: | | | | | | | | | | | | | | Outstanding restricted stock grants | | $ | 921,000 | | $ | 926,000 | | $ | 1,959,000 | | $ | 1,864,000 | | Outstanding RSUs | | | 326,000 | | | 370,000 | | | 555,000 | | | 778,000 | | Total charge to operations | | $ | 1,247,000 | | $ | 1,296,000 | | $ | 2,514,000 | | $ | 2,642,000 | |
| (a) | There were no RSUs granted during the three and six months ended June 30, 2026 and 2025. |
|